CA2893966C - Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids - Google Patents

Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids Download PDF

Info

Publication number
CA2893966C
CA2893966C CA2893966A CA2893966A CA2893966C CA 2893966 C CA2893966 C CA 2893966C CA 2893966 A CA2893966 A CA 2893966A CA 2893966 A CA2893966 A CA 2893966A CA 2893966 C CA2893966 C CA 2893966C
Authority
CA
Canada
Prior art keywords
use according
condition
aurin
ata
aha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2893966A
Other languages
English (en)
French (fr)
Other versions
CA2893966A1 (en
Inventor
Patrick L. Mcgeer
Moonhee Lee
Douglas N. Bell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurin Biotech Inc
Original Assignee
Aurin Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurin Biotech Inc filed Critical Aurin Biotech Inc
Publication of CA2893966A1 publication Critical patent/CA2893966A1/en
Application granted granted Critical
Publication of CA2893966C publication Critical patent/CA2893966C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2893966A 2012-12-06 2013-06-21 Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids Active CA2893966C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/694,484 US8877808B2 (en) 2012-12-06 2012-12-06 Protection against skin diseases by aurin tricarboxylic acid and its derivatives
US13/694,484 2012-12-06
PCT/CA2013/050488 WO2014085920A1 (en) 2012-12-06 2013-06-21 Methods for preventing and treating inflammatory skin conditions

Publications (2)

Publication Number Publication Date
CA2893966A1 CA2893966A1 (en) 2014-06-12
CA2893966C true CA2893966C (en) 2018-09-18

Family

ID=50881631

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2893966A Active CA2893966C (en) 2012-12-06 2013-06-21 Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids

Country Status (7)

Country Link
US (1) US8877808B2 (https=)
EP (1) EP2928460B1 (https=)
JP (1) JP2016501236A (https=)
KR (1) KR20150090920A (https=)
CN (1) CN104902886A (https=)
CA (1) CA2893966C (https=)
WO (1) WO2014085920A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588879B2 (en) 2011-08-01 2020-03-17 Aurin Biotech Inc. Treatment of age-related macular degeneration
ES2774776T3 (es) 2013-11-18 2020-07-22 Aurin Biotech Inc Dímeros de ácido acetilsalicílico, síntesis de los mismos, y usos de los mismos para prevenir y tratar trastornos mediados por complemento
US11013750B2 (en) 2017-01-20 2021-05-25 Aurin Biotech Inc. Methods for treating and preventing nociceptive pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007270A (en) 1975-11-18 1977-02-08 American Cyanamid Company Complement inhibitors
US5030442A (en) 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
DE4222534A1 (de) * 1992-07-09 1994-01-13 Behringwerke Ag Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
US5434185A (en) 1993-05-17 1995-07-18 The University Of Kentucky Research Foundation Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts
US6770633B1 (en) * 1999-10-26 2004-08-03 Immusol, Inc. Ribozyme therapy for the treatment of proliferative skin and eye diseases
JP2003530309A (ja) 1999-10-26 2003-10-14 イミューソル インコーポレイテッド 増殖性皮膚疾患又は増殖性眼疾患を治療するリボザイム療法
WO2001057184A2 (en) 2000-02-01 2001-08-09 Vanderbilt University Use of platelet activity modulators for inhibiting complement activation
JP2003525243A (ja) * 2000-02-28 2003-08-26 ザ ユニバーシティ オブ ブリティッシュ コロンビア 炎症性疾患の治療のための組成物及び方法
US20110189310A1 (en) 2008-10-08 2011-08-04 Cornell University Small molecule modulators of prongf uptake
US20130035392A1 (en) 2011-08-01 2013-02-07 Mcgeer Patrick L Selective inhibition of the membrane attack complex of complement and C3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex
US10966945B2 (en) 2011-08-01 2021-04-06 Aurin Biotech Inc. Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic synthetic complex
WO2014009779A1 (en) * 2012-07-13 2014-01-16 Aurin Biotech Inc. Selective inhibition of the membrane attack complex of complement and c3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex

Also Published As

Publication number Publication date
EP2928460A4 (en) 2016-08-17
EP2928460B1 (en) 2017-12-27
CN104902886A (zh) 2015-09-09
CA2893966A1 (en) 2014-06-12
US8877808B2 (en) 2014-11-04
JP2016501236A (ja) 2016-01-18
WO2014085920A1 (en) 2014-06-12
US20140163106A1 (en) 2014-06-12
EP2928460A1 (en) 2015-10-14
KR20150090920A (ko) 2015-08-06
WO2014085920A9 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
JP5570992B2 (ja) 皮膚病又は皮膚病変の治療方法及び組成物
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
JP2012184253A (ja) ざ瘡を治療するための組成物及び方法
CN111372595A (zh) 治疗皮肤的方法和组合物
JP2010502700A (ja) アクネを治療する医薬品、加齢および日焼けの症状を回復する医薬品、及び、これを用いた方法
KR20120118064A (ko) 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물
US20120258972A1 (en) Composition and Methods for Treating Hair Loss
CA2893966C (en) Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids
US20140199413A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
CN110769817A (zh) 皮肤治疗方法、含类视黄醇的组合物及其递送系统
US20200030398A1 (en) Skin care composition
WO2017129108A1 (zh) 一种用于治疗皮肤病的硅凝胶
JP2016501236A5 (https=)
CN111936130A (zh) 包含锶和甲基磺酰基甲烷（msm）的局部制剂及治疗方法
WO2016033899A1 (zh) 一种调节头皮油脂平衡的去屑组合物
WO2016144196A1 (en) A pharmaceutical and/or cosmetic composition for treating skin diseases and damages, the process for preparing of the pharmaceutical and/or cosmetic composition and its use
AU2020282051B2 (en) Composition containing fluoxetine and vitamin D 3 or its derivatives and application thereof
KR20220151931A (ko) 여드름 피부 개선용 화장료 조성물
US20040204492A1 (en) Topical composition and method for treating seborrheic dermatitis
US11298391B1 (en) Topical skin health improvement compositions and administrations thereof
KR20070000675A (ko) 녹두 추출물, 백급 추출물 및 승마 추출물을 포함하는조성물 및 이의 용도
EP1688145A1 (en) Methods and compositions for treating psoriasis
Fathi et al. Efficacy and Safety of Combination of Mometasone Furoate 0.1% Cream and Adapalene 0.1% Gel in Alopecia Areata
SK9764Y1 (sk) Prírodný dermálny krém na citlivú, ekzematickú a dermatóznu pokožku
KR20040024213A (ko) 홍삼 조사포닌을 함유하는 여드름 개선용 부직포 팩

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160622

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20241223